Last reviewed · How we verify
High Dose Maolactin
High Dose Maolactin is an immunomodulatory agent that modulates the immune system to treat various conditions.
High Dose Maolactin is an immunomodulatory agent that modulates the immune system to treat various conditions. Used for Pneumocystis jirovecii pneumonia (PCP) prophylaxis in HIV-infected patients.
At a glance
| Generic name | High Dose Maolactin |
|---|---|
| Sponsor | RDC Clinical Pty Ltd |
| Drug class | Immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
High Dose Maolactin works by enhancing the body's immune response to fight off infections and diseases. It is thought to stimulate the production of antibodies and activate immune cells to target and eliminate pathogens. The exact mechanisms of action are not fully understood.
Approved indications
- Pneumocystis jirovecii pneumonia (PCP) prophylaxis in HIV-infected patients
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High Dose Maolactin CI brief — competitive landscape report
- High Dose Maolactin updates RSS · CI watch RSS
- RDC Clinical Pty Ltd portfolio CI